OCTLIGHT engineers are currently putting the final touch on the second pilot series production of Caliper OEM modules. The modules are assembled as soon as PCB and TOSA-VCSELs have passed inspection and testing. After assembly the modules are tested with all optical components fiber coupled before fiber splicing. Then the modules are subjected to the final testing against specifications. The modules will go out to different parts of the world by the end of this summer.

OCTLIGHT has been selected to the Photonics Programme, which is the predecessor to the European Photonics Venture Forum. Through the program OCTLIGHT will work to refine strategies and look for new opportunities for leveraging its innovative tunable VCSEL technology platform. The program is aligned with OCTLIGHT mission to transform our technology into solutions that will make our society healthier, happier, and more sustainable.

OCTLIGHT breakthrough technology is already available as the product Caliper targeted at the Ophthalmic application of eye biometry. Get in contact today to discuss your needs for tunable single-mode, long-coherence length and kHz-MHz interferometric applications. To support our future product roadmap we are very interested to get in touch with system integrators about your future needs and applications using this Key Enabling Technology build out of the European world leading Photonics community.

The EU project NETLAS, which officialy began in February, was kicked off with a meeting between the beneficiaries and partners at Kent University in Canterbury the 20th of February 2020.

OCTLIGHT is a partner in the project and will participate with its innovative VCSEL OCT Swept Source technology especially focused on the application of Ophthalmology.

The project is aimed at developing new talents and educating future European industry leaders within the next generation within 12 different technologies. OCTLIGHT will aid as an example of novel optics configurations for tuneable lasers for sensing and imaging.

The institution at which OCTLIGHT’s technology has been developed, the Technical University of Denmark, will be a direct beneficiary of the NETLAS project, among others. We look forward to contributing to this important effort.

Read more about the project on the European Commission website

We will be present at Photonics West 2020 February 1-4 in San Francisco, California, USA. We look forward to update current customers on our progress and meet new to discuss applications of our OCT Swept Source.

Interested to hear about sampling of our 1060 nm VCSEL enabled OCT Swept Source with kHz and MHz sweep rates? Please fill out this contact form about your availability and we will return to you to schedule a meeting.

We are delighted to congratulate our CTO Kresten Yvind on his position as Professor of Nanophotonics at The Department of Photonics, Technical University of Denmark (DTU). Kresten will this afternoon give his inaugural lecture at DTU Building 101, Room M1 on the subject of “Nanofabrication of photonic devices for communication and medical diagnostics” – attendance open to all.

This is a fanatastic step for research within the field of nanophotonics as well as the VCSEL technology that is the core of OCTLIGHT products.

Alongside his professorship we are very pleased that co-founder Kresten will continue with his position as CTO. We look forward to continued collaboration with The Technical University of Denmark the coming years.

DTU is ranked as one of the foremost technical universities in Europe being the highest ranked in the Nordics of Reuters Top 100 World’s Most Innovative Universities

OCTLIGHT has for the second time been selected as one of the beneficiaries of the Horizon 2020 EU SME Instrument. Read the official press release here.

With the project “Innovative Swept Source for next generation OCT devices” OCTLIGHT will participate in Phase 1 of the instrument, granting the company €50,000 to be used for exploring and assessing the commercial potential of our technology.

This time around, the project will focus on developing a business plan for our second OCT product line, Ozzy, which utilizes our MEMS-VCSEL technology. The technology is currently being developed in our Eurostars funded project focusing on demonstrating MHz SS-OCT for wide-field Ophthalmic imaging.

The outcome will be a more solid understanding of the technology’s market potential as well as integration with the current market. This will benefit end-customers with an unmatched value proposition for a step change in performance of Ophthalmic imaging.

We are very excited to undergo this project. Be sure to subscribe to our newsletter for more information on our development progress.

Biophotonics is multifaceted and has significant potential for innovation. The industry will come together from June 24 to 27, 2019 in Munich for LASER World of PHOTONICS, the world’s leading trade fair with congress for photonics components, systems and applications. Half a year before the fair, more than 130 international exhibitors from all areas of biophotonics have already announced their attendance. Studies predict that the sector will achieve global sales of 85.5 billion Euros by 2020—with annual growth of seven percent.

LASER World of PHOTONICS, the world’s leading Trade Fair with Congress for Photonics Components, Systems and Applications, has more than 32,700 visitors from 73 countries and 1,290 exhibitors from 42 countries.

OCTLIGHT CEO, Thor Ansbæk, will be participating in the upcomming Laser World of Photonics exhibition from June 25 – 26 in Munich.

Give us a call or send an e-mail if you would like to schedule a meeting!

Phone: +45 53 86 27 | Mail: thor@octlight.com

Image is copyright of Messe München.

OCTLIGHT has been selected as being among the 50 most promising impact companies in the Nordics from 7000 screened startups.

CEO Thor Ersted Ansbæk comments:”We are honoured to have been selected between 1000 nordic startups and SME’s as in the top 50 of companies with an impact agenda. We are purpose driven with the mission to improve life quality, specifically eye health, by engaging with the healthcare community globally. According to WHO 285 million people worldwide are visually impaired and we work hard to enable early diagnosis necessary to prevent eye diseases from turning into blindness.”

We are really excited and humbled for the recognition for our work towards UN Sustainable Development Goals #sdgs #sustainabledevelopmentgoals

We thrive to improve quality of life worldwide together with our partners within the health community

After a very succesful Photonics West 2019, where OCTLIGHT exhibited in early February in order to engage with prospective customers, the OCTLIGHT production team has been hard at work to increase the through-put of VCSELs to ramp up our production.

From the Photonics West 2019 trade-show it was evident that VCSEL technology is seen to play a major role in upcoming OCT products for Ophthalmology with several announcements of advancement of 1060 nm wavelength tunable VCSEL technology.

Sample VCSEL wafers from the most recent wafer run.
Sample VCSEL wafers from the most recent production run. A 2″ VCSEL wafer contains more than 16,000 VCSELs which are binned after wafer-scale testing to meet specifications of the OCT Swept Source product.

The added effort put into the cleanroom semiconductor facilities has been fruitful, making the recent VCSEL wafer production run our most succesful yet.

The VCSELs will be put to use in Caliper OCT Swept Source modules for OEM sampling in 2019. VCSELs are also taken out for long-term reliability testing to document that OCTLIGHT VCSEL technology delivers the same reliability as well-established InGaAs VCSEL technology.

Take a look at our product page for more information about what our VCSELs are used for.

You can also call us on +45 53 86 27 37 for a discussion about how our technology might fit into your product roadmap.

Matter PR recently came by to create a story on OCTLIGHT and how we have grown and developed thanks to support from Actphast. The result is the following video where we showcase one of our prototypes and the laboratories we work in. CEO, Thor Ansbæk, was interviewed about the process and growing the company.

Read more about the story on Actphast’s website or in the articles made by Eyewire and BioOptics World